Related Posts

FDA Approves Device To Treat Obesity

  • meg
  • February 3, 2015
  • 0

Recently, the U.S. Food and Drug Administration approved the very first weight loss device that controls satiety. The Maestro Rechargeable System targets the neural pathway between the brain and the stomach that controls feelings of hunger and fullness. However, this device will only be available to adults aged 18 years …

Anti-Epilepsy Medication May Reduce The Effects of Stroke

  • meg
  • February 10, 2015
  • 0

Currently, new research suggests that the anticonvulsant medication, retigabine, could dramatically reduce the effects of stroke. Researchers have already recognized the potential of this medication in treating neurologic conditions, such as migraine, tinnitus and neuropathic pain. By observing mice models, researchers discovered that merely a single dose of retigabine prevented …